Ocugen, Inc.
OCGNNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $275.58M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.79$2.73
- Volume (live)
- -
- Avg. volume (3M)
- 8.59M
Ocugen (OCGN) Stock Price & Financial Analysis
Ocugen Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.78 - $0.84 |
|---|---|
| 52-Week High | $2.73 |
| 52-Week Low | $0.79 |
| Open | $0.84 |
| Volume (last close) | 5.12M |
| Average Volume (3M) | 8.59M |
| Revenue (TTM) | 4.58M |
|---|---|
| Net Income (TTM) | -81.81M |
| Free Cash Flow (TTM) | -61.02M |
| EPS (TTM) | −$0.26 |
| Profit Margin | -1786.27% |
| Operating Margin | -1504.43% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 275.58M |
|---|---|
| Shares Outstanding | 338.68M |
| Price to Sales (P/S) | 60.17 |
| Price to Book (P/B) | -16.65 |
| EV/EBITDA | -3.92 |
| 50-Day MA | $1.17 |
|---|---|
| 200-Day MA | $1.48 |
| 1-Year Change | −49.14% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Ocugen at a Glance
As of the Oct 16, 2026 close, Ocugen (OCGN) has a market capitalization of $275.58M. The stock trades at 60.2× sales. Over the trailing twelve months it lost $81.81M on revenue of $4.58M and burned $61.02M of free cash flow. Revenue fell 3.7% year over year.
As of its latest reported balance sheet, it holds $100.05M in cash and securities against $84.11M of debt, a net cash position of $15.94M.
Ocugen does not currently pay a dividend.
The share price is down 49.1% over the past year. At $0.78 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.79 to $2.73, below its 200-day moving average of $1.48.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $10.20, 1207.2% above the Oct 16, 2026 close.
Frequently Asked Questions About Ocugen
What is the current stock price for OCGN?
As of the Oct 16, 2026 close, OCGN stock trades at $0.78. The 52-week range is $0.79–$2.73, with a day range of $0.78–$0.84.
What is the P/E ratio for OCGN?
The P/E ratio (Price-to-Earnings) for OCGN is shown in the Key Statistics section. This valuation metric helps compare Ocugen, Inc. to industry peers.
Does OCGN pay dividends?
Ocugen does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for OCGN?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for OCGN is Buy. The average 12-month price target is $10.20, a 1207.2% upside from the Oct 16, 2026 close of $0.78.
What is the market cap of OCGN?
As of the Oct 16, 2026 close, Ocugen's market capitalization is $264.3M, classifying it as a micro-cap company. Ocugen operates in the Healthcare sector within the Biotechnology industry.